All categories
Science8 feeds
BioPharm International articles(biopharminternational.com)
<![CDATA[Flexibility and AI-driven Diligence Are Defining Biopharma Deal Strategy in 2026, Says Baker McKenzie's Oren Livne]]><![CDATA[Drug Digest: How Advanced Analytics Partnerships Enhance the Biopharma Value Chain]]><![CDATA[Executive Summary: The Road Ahead: What's Next for Host Cell Protein Analytics?]]><![CDATA[Why Gout's Straightforward Biology and Large Unmet Need Make It an Overlooked Drug Development Opportunity, says Dr James Mackay, Crystalys Therapeutics CEO]]><![CDATA[Novel Payloads and Multispecific Antibodies Fuel ADC Innovation]]><![CDATA[Beyond the Strip: Las Vegas Has a New Kind of Venture in Mind]]><![CDATA[Why CGT Manufacturing Still Faces Process Characterization and Scale-Up Challenges, According to MilliporeSigma’s Sebastián Arana]]>
Biotech / Medtech Archives | citybiz(citybiz.co)
Establishment Labs Appoints Taylor Harris to Board of DirectorsKailera Therapeutics Appoints Kathleen Tregoning Chief Corporate Affairs OfficerXilio Therapeutics Appoints Ben Harshbarger as Chief Legal OfficerNovaBridge Biosciences Names Dr. Srishti Gupta CEO to Lead Clinical Development StrategyJoe Montana Joins $120M Series C for Voice AI Venture Assort HealthQ&A with David Lazerson, Co-Founder & CEO of BriyaDirectTrust Appoints New Board Members and EHNAC Commissioners
Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug CollaborationBacked by $165M, Bionyra Pharma Launches to Advance Inflammatory Disease BiologicsGenome Editing at the Turning Point—Bringing CRISPR to Clinical RealityIntravesical CAR T-Cell Therapy Reduces Bladder Cancer Growth in Preclinical ModelNipah and Hendra Viruses: Antibody Cocktail Provides Complete Protection in Hamster ModelCircio’s circVec and Tcelltech’s nanoSMAR Technologies Combined to Generate Nextgen In vivo CAR-T and TCR-T CellsAI Framework Surfaces New CAR T Target with Multi‑Cancer Potential
Podcast: Why HPC is Absolutely Ready for the CloudIndustry Leaders on the Promise & Peril of NSCITim Carroll Joins Cycle Computing, Discusses HPC Cloud FutureUpdate on the HPCG BenchmarkDr. Lorena Barba Talks “Women Who CUDA”Virtual Observatories for Big Scientific DataReal World Performance Gains with CUDA 6
Gene therapy restores immune function to infants with SCID-X1 (X-linked severe combined immunodeficiency)Gene therapy company buyouts are making the newsTargeting solid tumors with natural killer (NK) cellsNobel Prize in Medicine for discovery of cancer immunotherapy via checkpoint inhibitionAlnylam’s patisiran, the first ever FDA- and European Commission-approved RNAi therapeuticNewLink Genetics—new organizational and clinical trial strategy for development of its cancer immunotherapy drug indoximodMIT study finds that the probability of clinical trial success is nearly 40% higher than previously thought
Error Analysis for Deep ReLU Feedforward Density-Ratio Estimation with Bregman Divergence
Finite Neural Networks as Mixtures of Gaussian Processes: From Provable Error Bounds to Prior Selection
Nonlocal Techniques for the Analysis of Deep ReLU Neural Network Approximations
Boosted Control Functions: Distribution Generalization and Invariance in Confounded Models
Efficient frequent directions algorithms for approximate decomposition of matrices and higher-order tensors
Transformers Can Overcome the Curse of Dimensionality: A Theoretical Study from an Approximation Perspective
Unsupervised Feature Selection via Nonnegative Orthogonal Constrained Regularized Minimization
Merck Signs $20M Deal With Quotient to Find IBD Targets Using Somatic GenomicsLilly Signs $2.75B AI Drug Discovery Deal With InsilicoAnthropic Pays $400M for an AI Biotech With Fewer Than Ten PeopleAI-Guided Brain Implant for Memory Loss Gets FDA Breakthrough StatusNovo Nordisk and OpenAI Team Up to Integrate AI from Discovery to Supply ChainGenerare Raises €20M to Explore Uncharacterized Chemical Space from Microbial DNAEarendil Labs Gets $787M to Push AI-Designed Antibodies Toward the Clinic
Immunai and Boehringer partner to identify T-cell targetsTryngolza charts blockbuster course after FDA’s hypertriglyceridemia approvalLilly-backed Absci banks $100m to progress endometriosis, hair loss therapyIonis grants Recordati rights to zilganersen for Alexander diseaseBIO 2026: Former FDA staff question agency’s “radical transparency” approachMerck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansionN. America job signals: What leaders need to know about the healthtech hiring squeeze